| 1 |
Schult D, Rasch S, Schmid RM, Lahmer T, Mayr U. EASIX Is an Accurate and Easily Available Prognostic Score in Critically Ill Patients with Advanced Liver Disease. JCM 2023;12:2553. [DOI: 10.3390/jcm12072553] [Reference Citation Analysis]
|
| 2 |
Jeong JH, Lee SB, Sung A, Shin H, Kim DH. Factors predicting mortality in patients with alcoholic liver cirrhosis visiting the emergency department. Medicine (Baltimore) 2023;102:e33074. [PMID: 36827072 DOI: 10.1097/MD.0000000000033074] [Reference Citation Analysis]
|
| 3 |
Rodríguez-blanco JD, Martínez-ávila MC, Almanza-hurtado AJ, Rodríguez-yanez T, Imbeth-acosta PL. Infecciones bacterianas en cirrosis: desafíos y perspectivas. Acta Colombiana de Cuidado Intensivo 2022;22:209-216. [DOI: 10.1016/j.acci.2021.04.001] [Reference Citation Analysis]
|
| 4 |
Zhang S, Ji B, Zhong X, Zhong L, Yang L, Yang C. A Dynamic Nomogram Predicting Portal Vein Thrombosis in Cirrhotic Patients During Primary Prophylaxis for Variceal Hemorrhage. Front Med 2022;9:887995. [DOI: 10.3389/fmed.2022.887995] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Albillos A, Martin-Mateos R, Van der Merwe S, Wiest R, Jalan R, Álvarez-Mon M. Cirrhosis-associated immune dysfunction. Nat Rev Gastroenterol Hepatol 2022;19:112-34. [PMID: 34703031 DOI: 10.1038/s41575-021-00520-7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 28.0] [Reference Citation Analysis]
|
| 6 |
Tornai D, Vitalis Z, Jonas A, Janka T, Foldi I, Tornai T, Sipeki N, Csillag A, Balogh B, Sumegi A, Foldesi R, Papp M, Antal-Szalmas P. Increased sTREM-1 levels identify cirrhotic patients with bacterial infection and predict their 90-day mortality. Clin Res Hepatol Gastroenterol 2021;45:101579. [PMID: 33773436 DOI: 10.1016/j.clinre.2020.11.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 7 |
Curakova Ristovska E. Endothelial Dysfunction and Systemic Inflammation in the Pathogenesis and Progression of Portal Hypertension. Portal Hypertension - Recent Advances 2021. [DOI: 10.5772/intechopen.96172] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 8 |
Miranda-Zazueta G, León-Garduño LAP, Aguirre-Valadez J, Torre-Delgadillo A. Bacterial infections in cirrhosis: Current treatment. Ann Hepatol 2020;19:238-44. [PMID: 32317149 DOI: 10.1016/j.aohep.2019.09.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 9 |
Gavrilenko DI, Silivontchik N. Translocation of gut microbiota in liver cirrhosis: mechanisms, clinical significance, and markers. CMAC 2021;23:147-160. [DOI: 10.36488/cmac.2021.2.147-160] [Reference Citation Analysis]
|
| 10 |
Mayr U, Lukas M, Elnegouly M, Vogt C, Bauer U, Ulrich J, Schmid RM, Huber W, Lahmer T. Ascitic Interleukin 6 Is Associated with Poor Outcome and Spontaneous Bacterial Peritonitis: A Validation in Critically Ill Patients with Decompensated Cirrhosis. J Clin Med 2020;9:E2865. [PMID: 32899730 DOI: 10.3390/jcm9092865] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 11 |
Mayr U, Pfau J, Lukas M, Bauer U, Herner A, Rasch S, Schmid RM, Huber W, Lahmer T, Batres-Baires G. NUTRIC and Modified NUTRIC are Accurate Predictors of Outcome in End-Stage Liver Disease: A Validation in Critically Ill Patients with Liver Cirrhosis. Nutrients 2020;12:E2134. [PMID: 32709104 DOI: 10.3390/nu12072134] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 12 |
Chen SH, Wan QS, Wang T, Zhang KH. Fluid Biomarkers for Predicting the Prognosis of Liver Cirrhosis. Biomed Res Int 2020;2020:7170457. [PMID: 32280697 DOI: 10.1155/2020/7170457] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 13 |
Elsadek HM, Elhawari SA, Mokhtar A. A novel serum index for accurate diagnosis of spontaneous bacterial peritonitis in cirrhotic patients without other infections. Egypt Liver Journal 2020;10. [DOI: 10.1186/s43066-020-0021-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 14 |
Engelmann C, Tacke F. Dekompensierte Leberzirrhose und akut-auf-chronisches Leberversagen. Gastroenterologe 2020;15:22-33. [DOI: 10.1007/s11377-019-00407-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 15 |
Fischer P, Grigoras C, Bugariu A, Nicoara-Farcau O, Stefanescu H, Benea A, Hadade A, Margarit S, Sparchez Z, Tantau M, Ionescu D, Procopet B. Are presepsin and resistin better markers for bacterial infection in patients with decompensated liver cirrhosis? Dig Liver Dis 2019;51:1685-91. [PMID: 31221548 DOI: 10.1016/j.dld.2019.05.025] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 16 |
Luo J, Wu X, Zhang Y, Huang W, Jia B. Role of ascitic prostaglandin E2 in diagnosis of spontaneous bacterial peritonitis and prediction of in-hospital mortality in patients with decompensated cirrhosis. Medicine (Baltimore) 2019;98:e16016. [PMID: 31261505 DOI: 10.1097/MD.0000000000016016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 17 |
Mani I, Alexopoulou A, Vasilieva L, Hadziyannis E, Agiasotelli D, Bei M, Alexopoulos T, Dourakis SP. Human beta-defensin-1 is a highly predictive marker of mortality in patients with acute-on-chronic liver failure. Liver Int 2019;39:299-306. [PMID: 30261128 DOI: 10.1111/liv.13977] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 18 |
Khedher S, Fouthaili N, Maoui A, Lahiani S, Salem M, Bouzid K. The Diagnostic and Prognostic Values of C-Reactive Protein and Procalcitonin during Bacterial Infections in Decompensated Cirrhosis. Gastroenterol Res Pract 2018;2018:5915947. [PMID: 31582968 DOI: 10.1155/2018/5915947] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 19 |
Righi E. Management of bacterial and fungal infections in end stage liver disease and liver transplantation: Current options and future directions. World J Gastroenterol 2018; 24(38): 4311-4329 [PMID: 30344417 DOI: 10.3748/wjg.v24.i38.4311] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 28] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 20 |
Wang H, Li Y, Zhang F, Yang N, Xie N, Mao Y, Li B. Combination of PCT, sNFI and dCHC for the diagnosis of ascites infection in cirrhotic patients. BMC Infect Dis 2018;18:389. [PMID: 30097024 DOI: 10.1186/s12879-018-3308-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 21 |
Engelmann C, Berg T. Management of Infectious Complications Associated with Acute-on-Chronic Liver Failure. Visc Med. 2018;34:261-268. [PMID: 30345283 DOI: 10.1159/000491107] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 22 |
Palyu E, Harsfalvi J, Tornai T, Papp M, Udvardy M, Szekeres-Csiki K, Pataki L, Vanhoorelbeke K, Feys HB, Deckmyn H, Tornai I. Major Changes of von Willebrand Factor Multimer Distribution in Cirrhotic Patients with Stable Disease or Acute Decompensation. Thromb Haemost 2018;118:1397-408. [PMID: 29972862 DOI: 10.1055/s-0038-1661393] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 23 |
Perdigoto DN, Figueiredo PN, Tomé LF. Clarifying the role of C-reactive protein as a bacterial infection predictor in decompensated cirrhosis. Eur J Gastroenterol Hepatol 2018;30:645-51. [PMID: 29384797 DOI: 10.1097/MEG.0000000000001081] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 24 |
Yeoh SF, Lee TJ, Chew KL, Lin S, Yeo D, Setia S. Echinocandins for management of invasive candidiasis in patients with liver disease and liver transplantation. Infect Drug Resist. 2018;11:805-819. [PMID: 29881298 DOI: 10.2147/idr.s165676] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 25 |
Piano S, Brocca A, Mareso S, Angeli P. Infections complicating cirrhosis. Liver Int 2018;38 Suppl 1:126-33. [PMID: 29427501 DOI: 10.1111/liv.13645] [Cited by in Crossref: 97] [Cited by in F6Publishing: 98] [Article Influence: 19.4] [Reference Citation Analysis]
|
| 26 |
Zhang X, Chen P, Gao H, Hao S, Yang M, Zhao H, Hu J, Ma W, Li L. Bacterial Infection and Predictors of Mortality in Patients with Autoimmune Liver Disease-Associated Acute-On-Chronic Liver Failure. Can J Gastroenterol Hepatol 2018;2018:5108781. [PMID: 29623264 DOI: 10.1155/2018/5108781] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 27 |
Deutsch M, Manolakopoulos S, Andreadis I, Giannaris M, Kontos G, Kranidioti H, Pirounaki M, Koskinas J. Bacterial infections in patients with liver cirrhosis: clinical characteristics and the role of C-reactive protein. Ann Gastroenterol 2018;31:77-83. [PMID: 29333070 DOI: 10.20524/aog.2017.0207] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 28 |
Piano S, Morando F, Carretta G, Tonon M, Vettore E, Rosi S, Stanco M, Pilutti C, Romano A, Brocca A, Sticca A, Donato D, Angeli P. Predictors of Early Readmission in Patients With Cirrhosis After the Resolution of Bacterial Infections. Am J Gastroenterol 2017;112:1575-83. [PMID: 28853729 DOI: 10.1038/ajg.2017.253] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 29 |
Nier A, Engstler AJ, Maier IB, Bergheim I. Markers of intestinal permeability are already altered in early stages of non-alcoholic fatty liver disease: Studies in children. PLoS One 2017;12:e0183282. [PMID: 28880885 DOI: 10.1371/journal.pone.0183282] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 30 |
La Mura V, Salerno F. Reply to the diagnostic conundrum of bacterial infections in cirrhotic patients. Liver Int 2017;37:1412. [PMID: 28845619 DOI: 10.1111/liv.13474] [Reference Citation Analysis]
|
| 31 |
Alexopoulou A, Agiasotelli D, Vasilieva LE, Dourakis SP. Bacterial translocation markers in liver cirrhosis. Ann Gastroenterol. 2017;30:486-497. [PMID: 28845103 DOI: 10.20524/aog.2017.0178] [Cited by in Crossref: 20] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 32 |
de Oliveira VM, Moraes RB, Stein AT, Wendland EM. Accuracy of C - Reactive protein as a bacterial infection marker in critically immunosuppressed patients: A systematic review and meta-analysis. J Crit Care 2017;42:129-37. [PMID: 28735154 DOI: 10.1016/j.jcrc.2017.07.025] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 33 |
El-emshaty W, Mashaly M, Moawad A, Elgamal M, Hewidy A. Diagnostic value of neutrophil-lymphocyte ratio versus C-reactive protein in discrimination between different pathogens causing community-acquired pneumonia. Comp Clin Pathol 2017;26:757-765. [DOI: 10.1007/s00580-017-2443-1] [Reference Citation Analysis]
|
| 34 |
Foldi I, Tornai T, Tornai D, Sipeki N, Vitalis Z, Tornai I, Dinya T, Antal-Szalmas P, Papp M. Lectin-complement pathway molecules are decreased in patients with cirrhosis and constitute the risk of bacterial infections. Liver Int 2017;37:1023-31. [PMID: 28109038 DOI: 10.1111/liv.13368] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 35 |
Agiasotelli D, Alexopoulou A, Vasilieva L, Hadziyannis E, Goukos D, Daikos GL, Dourakis SP. High serum lipopolysaccharide binding protein is associated with increased mortality in patients with decompensated cirrhosis. Liver Int 2017;37:576-82. [PMID: 27712029 DOI: 10.1111/liv.13264] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 36 |
Papp M, Tornai T, Vitalis Z, Tornai I, Tornai D, Dinya T, Sumegi A, Antal-Szalmas P. Presepsin teardown - pitfalls of biomarkers in the diagnosis and prognosis of bacterial infection in cirrhosis. World J Gastroenterol 2016; 22(41): 9172-9185 [PMID: 27895404 DOI: 10.3748/wjg.v22.i41.9172] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 37 |
Tornai T, Vitalis Z, Sipeki N, Dinya T, Tornai D, Antal-Szalmas P, Karanyi Z, Tornai I, Papp M. Macrophage activation marker, soluble CD163, is an independent predictor of short-term mortality in patients with cirrhosis and bacterial infection. Liver Int 2016;36:1628-38. [PMID: 27031405 DOI: 10.1111/liv.13133] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 38 |
Waidmann O, Brunner F, Herrmann E, Zeuzem S, Piiper A, Kronenberger B. Cytokeratin 18-based cell death markers indicate severity of liver disease and prognosis of cirrhotic patients. Liver Int 2016;36:1464-72. [PMID: 26991828 DOI: 10.1111/liv.13117] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 39 |
Nanchal RS, Ahmad S. Infections in Liver Disease. Critical Care Clinics 2016;32:411-24. [DOI: 10.1016/j.ccc.2016.03.006] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 40 |
Martín-mateos R, Mateos B, Lledó J, Téllez L, Albillos A. Infecciones bacterianas en la cirrosis. Medicine - Programa de Formación Médica Continuada Acreditado 2016;12:666-672. [DOI: 10.1016/j.med.2016.05.020] [Reference Citation Analysis]
|
| 41 |
Bunchorntavakul C, Chamroonkul N, Chavalitdhamrong D. Bacterial infections in cirrhosis: A critical review and practical guidance. World J Hepatol 2016;8:307-21. [PMID: 26962397 DOI: 10.4254/wjh.v8.i6.307] [Cited by in Crossref: 111] [Cited by in F6Publishing: 116] [Article Influence: 15.9] [Reference Citation Analysis]
|
| 42 |
Bartoletti M, Giannella M, Lewis RE, Viale P. Bloodstream infections in patients with liver cirrhosis. Virulence. 2016;7:309-319. [PMID: 26864729 DOI: 10.1080/21505594.2016.1141162] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 6.6] [Reference Citation Analysis]
|
| 43 |
McPherson S, Dyson J, Austin A, Hudson M. Response to the NCEPOD report: development of a care bundle for patients admitted with decompensated cirrhosis-the first 24 h. Frontline Gastroenterol 2016;7:16-23. [PMID: 26834955 DOI: 10.1136/flgastro-2014-100491] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 44 |
Yang Y, Li L, Qu C, Zeng B, Liang S, Luo Z, Wang X, Zhong C. Diagnostic Accuracy of Serum Procalcitonin for Spontaneous Bacterial Peritonitis Due to End-stage Liver Disease: A Meta-analysis. Medicine (Baltimore) 2015;94:e2077. [PMID: 26656333 DOI: 10.1097/MD.0000000000002077] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 45 |
Conti F, Dall'Agata M, Gramenzi A, Biselli M. Biomarkers for the early diagnosis of bacterial infection and the surveillance of hepatocellular carcinoma in cirrhosis. Biomark Med 2015;9:1343-51. [PMID: 26580585 DOI: 10.2217/bmm.15.100] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 46 |
Martínez-Esparza M, Tristán-Manzano M, Ruiz-Alcaraz AJ, García-Peñarrubia P. Inflammatory status in human hepatic cirrhosis. World J Gastroenterol 2015; 21(41): 11522-11541 [PMID: 26556984 DOI: 10.3748/wjg.v21.i41.11522] [Cited by in CrossRef: 47] [Cited by in F6Publishing: 51] [Article Influence: 5.9] [Reference Citation Analysis]
|
| 47 |
Kwon JH, Jang JW, Kim YW, Lee SW, Nam SW, Jaegal D, Lee S, Bae SH. The usefulness of C-reactive protein and neutrophil-to-lymphocyte ratio for predicting the outcome in hospitalized patients with liver cirrhosis. BMC Gastroenterol 2015;15:146. [PMID: 26498833 DOI: 10.1186/s12876-015-0378-z] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 48 |
Ximenes RO, Farias AQ, Scalabrini Neto A, Diniz MA, Kubota GT, Ivo MM, Colacique CG, D’Albuquerque LA, Daglius Dias R. Patients with cirrhosis in the ED: early predictors of infection and mortality. Am J Emerg Med. 2016;34:25-29. [PMID: 26423777 DOI: 10.1016/j.ajem.2015.09.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 49 |
Gálvez-Martínez M, Servín-Caamaño AI, Pérez-Torres E, Salas-Gordillo F, Rivera-Gutiérrez X, Higuera-de la Tijera F. Mean platelet volume as a novel predictor of systemic inflammatory response in cirrhotic patients with culture-negative neutrocytic ascites. World J Hepatol 2015;7:1001-6. [PMID: 25954482 DOI: 10.4254/wjh.v7.i7.1001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 50 |
Park JK, Lee CH, Kim IH, Kim SM, Jang JW, Kim SH, Kim SW, Lee SO, Lee ST, Kim DG. Clinical characteristics and prognostic impact of bacterial infection in hospitalized patients with alcoholic liver disease. J Korean Med Sci 2015;30:598-605. [PMID: 25931791 DOI: 10.3346/jkms.2015.30.5.598] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 51 |
Coll M, Solà E, Sancho-bru P. Prediction of Complications of Cirrhosis: Molecular Biomarkers. Complications of Cirrhosis 2015. [DOI: 10.1007/978-3-319-13614-1_3] [Reference Citation Analysis]
|
| 52 |
Kumar K, Mohindra S, Raj M, Choudhuri G. Procalcitonin as a marker of sepsis in alcoholic hepatitis. Hepatol Int. 2014;8:436-442. [PMID: 26202645 DOI: 10.1007/s12072-014-9540-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 53 |
Jalan R, Fernandez J, Wiest R, Schnabl B, Moreau R, Angeli P, Stadlbauer V, Gustot T, Bernardi M, Canton R, Albillos A, Lammert F, Wilmer A, Mookerjee R, Vila J, Garcia-Martinez R, Wendon J, Such J, Cordoba J, Sanyal A, Garcia-Tsao G, Arroyo V, Burroughs A, Ginès P. Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013. J Hepatol 2014;60:1310-24. [PMID: 24530646 DOI: 10.1016/j.jhep.2014.01.024] [Cited by in Crossref: 568] [Cited by in F6Publishing: 604] [Article Influence: 63.1] [Reference Citation Analysis]
|
| 54 |
Lin KH, Wang FL, Wu MS, Jiang BY, Kao WL, Chao HY, Wu JY, Lee CC. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection in patients with liver cirrhosis: a systematic review and meta-analysis. Diagn Microbiol Infect Dis. 2014;80:72-78. [PMID: 24974271 DOI: 10.1016/j.diagmicrobio.2014.03.029] [Cited by in Crossref: 54] [Cited by in F6Publishing: 62] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 55 |
Attar BM, Moore CM, George M, Ion-Nedelcu N, Turbay R, Zachariah A, Ramadori G, Fareed J, Thiel DHV. Procalcitonin, and cytokines document a dynamic inflammatory state in non-infected cirrhotic patients with ascites. World J Gastroenterol 2014; 20(9): 2374-2382 [PMID: 24605035 DOI: 10.3748/wjg.v20.i9.2374] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 56 |
Fagiuoli S, Colli A, Bruno R, Burra P, Craxì A, Gaeta GB, Grossi P, Mondelli MU, Puoti M, Sagnelli E, Stefani S, Toniutto P. Management of infections in cirrhotic patients: report of a consensus conference. Dig Liver Dis 2014;46:204-12. [PMID: 24021271 DOI: 10.1016/j.dld.2013.07.015] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 57 |
Lesińska M, Hartleb M, Gutkowski K, Nowakowska-Duława E. Procalcitonin and macrophage inflammatory protein-1 beta (MIP-1β) in serum and peritoneal fluid of patients with decompensated cirrhosis and spontaneous bacterial peritonitis. Adv Med Sci 2014;59:52-6. [PMID: 24797975 DOI: 10.1016/j.advms.2013.07.006] [Cited by in Crossref: 33] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 58 |
Attar BM, George M, Ion-Nedelcu N, Ramadori G, Thiel DH. Disease dependent qualitative and quantitative differences in the inflammatory response to ascites occurring in cirrhotics. World J Hepatol 2014;6:85-91. [PMID: 24575167 DOI: 10.4254/wjh.v6.i2.85] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 59 |
Yuan LY, Ke ZQ, Wang M, Li Y. Procalcitonin and C-reactive protein in the diagnosis and prediction of spontaneous bacterial peritonitis associated with chronic severe hepatitis B. Ann Lab Med. 2013;33:449-454. [PMID: 24205495 DOI: 10.3343/alm.2013.33.6.449] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 60 |
Papp M, Sipeki N, Vitalis Z, Tornai T, Altorjay I, Tornai I, Udvardy M, Fechner K, Jacobsen S, Teegen B, Sumegi A, Veres G, Lakatos PL, Kappelmayer J, Antal-Szalmas P. High prevalence of IgA class anti-neutrophil cytoplasmic antibodies (ANCA) is associated with increased risk of bacterial infection in patients with cirrhosis. J Hepatol 2013;59:457-66. [PMID: 23639483 DOI: 10.1016/j.jhep.2013.04.018] [Cited by in Crossref: 25] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 61 |
Lazzarotto C, Ronsoni MF, Fayad L, Nogueira CL, Bazzo ML, Narciso-Schiavon JL, de Lucca Schiavon L, Dantas-Corrêa EB. Acute phase proteins for the diagnosis of bacterial infection and prediction of mortality in acute complications of cirrhosis. Ann Hepatol 2013;12:599-607. [PMID: 23813138] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 62 |
Peter J, Frey O, Stallmach A, Bruns T. Attenuated antigen-specific T cell responses in cirrhosis are accompanied by elevated serum interleukin-10 levels and down-regulation of HLA-DR on monocytes. BMC Gastroenterol. 2013;13:37. [PMID: 23446058 DOI: 10.1186/1471-230x-13-37] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 63 |
Runyon BA. Acute phase proteins in patients with cirrhosis. Liver Int 2012;32:526-7. [PMID: 22404976 DOI: 10.1111/j.1478-3231.2011.02746.x] [Reference Citation Analysis]
|
